Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Scilex Holding Company (SCLX : NSDQ)

• Company Description    Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif. Number of Employees: 34

• Price / Volume Information    Yesterday's Closing Price: $2.35 Daily Weekly Monthly 20 Day Moving Average: 46,829 shares Shares Outstanding: 8.49 (millions) Market Capitalization: $19.96 (millions) Beta: 1.72 52 Week High: $27.00 52 Week Low: $2.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -51.94% -51.19% 12 Week -64.74% -65.36% Year To Date -80.74% -82.70%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 960 SAN ANTONIO ROAD - PALO ALTO,CA 94303 USA ph: 650-516-4310 fax: - investorrelations@scilexholding.com http://www.scilexholding.com

• General Corporate Information    Officers Henry Ji - Chief Executive Officer; President; Chairperson an Stephen Ma - Chief Financial Officer; Chief Operating Officer; Dorman Followwill - Director Jay Chun - Director Yue Alexander - Director Peer Information Scilex Holding Company (CORR.) Scilex Holding Company (RSPI) Scilex Holding Company (CGXP) Scilex Holding Company (BGEN) Scilex Holding Company (GTBP) Scilex Holding Company (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 80880W205 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 8.49 Most Recent Split Date: 4.00 (0.03:1) Beta: 1.72 Market Capitalization: $19.96 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.63 EPS Growth vs. Year Ago Period: -124.39% vs. Previous Quarter: -249.79% Sales Growth vs. Year Ago Period: -22.78% vs. Previous Quarter: -11.27% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - -147.00 03/31/26 - -143.55 Current Ratio 09/30/26 - - 06/30/26 - 0.07 03/31/26 - 0.08 Quick Ratio 09/30/26 - - 06/30/26 - 0.06 03/31/26 - 0.07 Operating Margin 09/30/26 - - 06/30/26 - -1,381.32 03/31/26 - -1,079.14 Net Margin 09/30/26 - - 06/30/26 - -1,414.57 03/31/26 - -1,110.17 Pre-Tax Margin 09/30/26 - - 06/30/26 - -1,469.71 03/31/26 - -1,162.36 Book Value 09/30/26 - - 06/30/26 - -36.57 03/31/26 - -29.92 Inventory Turnover 09/30/26 - - 06/30/26 - 3.86 03/31/26 - 4.23 Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©